Avery Therapeutics, Inc. funding
Avery Therapeutics, Inc., a biotechnology company based in Tucson, AZ, filed a Form D with the SEC on September 21, 2026 and reported $8.5M raised of a $15.4M offering.
Amount raised$8.5M
Offering size$15.4M
Filed with the SECSeptember 21, 2026
First saleAugust 19, 2026
IndustryBiotechnology
SecuritiesEquity
LocationTucson, AZ
FoundedMore than 5 years ago
Entity typeCorporation
Investors so far23
Minimum investment—
Revenue rangeDecline to Disclose
View the original Form D on SEC EDGAR ↗ · All rounds filed Sep 21